Regulatory Beat

Jul 01, 2013
BioPharm International
Increased manufacturer outsourcing requires clear policies and written agreements with CMOs.
Jun 01, 2013
BioPharm International
Companies can use metrics as a tool to help drive positive change and quality process improvements.
Jun 01, 2013
BioPharm International
A science- and risk-based approach to verify and demonstrate that a process operating within predefined specified parameters consistently produces material that meets all its critical quality attributes.
Jun 01, 2013
BioPharm International
Bills to regulate drug compounding and establish a national track and trace system face political and policy differences.
May 01, 2013
BioPharm International
Manufacturers work with international authorities to harmonize drug registration and supply-chain oversight.
Apr 01, 2013
BioPharm International
Opioid abuse generates calls for efforts to curb distribution.
Mar 01, 2013
BioPharm International
Vaccine development is benefiting from manufacturing advances.
Feb 01, 2013
BioPharm International
Shortages spur efforts to overhaul manufacturing oversight.
Jan 01, 2013
BioPharm International
Shortages spur efforts to overhaul manufacturing oversight.
Dec 01, 2012
BioPharm International
White House and Congress likely to struggle over funding for bio/pharmaceutical regulation.
native1_300x100
lorem ipsum